Daiwa: China Resources Medical (01515.HK) interim profit falls short of expectations "Reduce" rating, target price of 3 Hong Kong dollars.

Zhixin Finance APP learned that Morgan Stanley released a research report stating that China Resources Medical (01515.HK) issued a profit warning for the first half of this year, with net profit attributable to common shareholders expected to decrease by 20% to 25% year-on-year. Excluding the 210 million yuan compensation related to the "Yanhua IOT agreement," basic business profit will decrease by 55% to 60% year-on-year, lower than market consensus and Morgan Stanley's estimate. Morgan Stanley gave China Resources Medical a target price of 3 Hong Kong dollars and a "reduce" rating.